Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael W Simon

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Clinical Pediatrics|October 21, 2004
Changes in newborn bathing practices may increase the risk for omphalitisNeal P Simon, Michael W Simon
Drugs in R&D|January 9, 2003
Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illnessMichael W Simon, Douglas N Fish, Robert G Deeter
The Pediatric Infectious Disease Journal|August 28, 2020
Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Meningococcal-Naïve Children 2-9 Years of Age: A Phase III, Randomized StudyCarmen I Baccarini, Michael W Simon, Donald Brandon, et al.
Human Vaccines & Immunotherapeutics|March 27, 2020
Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized studyGermán Áñez, James Hedrick, Michael W Simon, et al.
The Pediatric Infectious Disease Journal|August 6, 2011
Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of age: results from a randomized open trialCosette M Wheeler, Bryan M Harvey, Michael E Pichichero, et al.
Human Vaccines & Immunotherapeutics|November 6, 2023
Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 randomized trialMichael W Simon, Regine Bataille, Nicole S Caldwell, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Clinical Pediatrics|October 21, 2004
Changes in newborn bathing practices may increase the risk for omphalitisNeal P Simon, Michael W Simon
Drugs in R&D|January 9, 2003
Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illnessMichael W Simon, Douglas N Fish, Robert G Deeter
The Pediatric Infectious Disease Journal|August 28, 2020
Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Meningococcal-Naïve Children 2-9 Years of Age: A Phase III, Randomized StudyCarmen I Baccarini, Michael W Simon, Donald Brandon, et al.
Human Vaccines & Immunotherapeutics|March 27, 2020
Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized studyGermán Áñez, James Hedrick, Michael W Simon, et al.
The Pediatric Infectious Disease Journal|August 6, 2011
Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of age: results from a randomized open trialCosette M Wheeler, Bryan M Harvey, Michael E Pichichero, et al.
Human Vaccines & Immunotherapeutics|November 6, 2023
Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 randomized trialMichael W Simon, Regine Bataille, Nicole S Caldwell, et al.
Pageof 2